Search

Subject CML -- MYELOFIBROS -- HEMATOPATHOLOGY

1. Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Issue 9 (25th January 2016)

Authors:
Tanrikulu Simsek, Eda; Eskazan, Ahmet Emre; Cengiz, Mahir; Ar, Muhlis Cem; Ekizoglu, Seda; Salihoglu, Ayse; Gulturk, Emine; Elverdi, Tugrul; Ongoren Aydin, Seniz; Senem Demiroz, Ahu; Buyru, Ayse Nur; Baslar, Zafer; Ozbek, Ugur; Ferhanoglu, Burhan; Aydin, Yildiz; Tuzuner, Nukhet; Soysal, Teoman
Journal:
Journal of clinical pathology
Issue:
Volume 69:Issue 9(2016)
Page Start:
810
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • CML -- MYELOFIBROS -- HEMATOPATHOLOGY 1